Don Manning is a notable inventor based in Bloomsbury, NJ (US). He has made significant contributions to the field of pain management through his innovative work. His research focuses on therapeutic agents that can effectively modulate nociceptive signaling.

Latest Patents

Manning holds a patent for "Oligonucleotide decoys for the treatment of pain." This patent provides therapeutic agents, specifically double-stranded nucleic acids known as oligonucleotide decoys. These agents are designed to prevent and treat pain by modulating nociceptive signaling.

Career Highlights

Don Manning is currently associated with Adynxx, Inc., where he continues to develop groundbreaking solutions for pain management. His work has the potential to transform the way pain is treated, offering new hope to those suffering from chronic pain conditions.

Collaborations

Manning collaborates with talented individuals such as Julien Mamet and Rick Orr. Their combined expertise enhances the innovative efforts at Adynxx, Inc.

Conclusion

Don Manning's contributions to pain treatment through his patented innovations highlight his role as a key figure in the field. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.